Colorectal Cancer Incidence Patterns in the United States, 1974-2013.
Rebecca L Siegel, Stacey A Fedewa, William F Anderson...
https://pubmed.ncbi.nlm.nih.gov/28376186/Actively Recruiting
Led by Massachusetts General Hospital · Updated on 2025-11-14
2
Participants Needed
4
Research Sites
N/A
Total Duration
This research aims to improve colorectal cancer screening by identifying and addressing barriers in community health centers CHCs with diverse populations. The study focuses on people aged 45 and older, examining baseline screening needs and disparities. Researchers will analyze electronic health records and use focus groups with CHC staff to understand screening challenges and perceptions about screening age changes and strategies. The study also seeks to develop and test ways to improve screening at patient, provider, and system levels using rapid cycle testing. The study involves several steps first, analyzing data from health records and population management platforms to understand screening patterns and resource needs. Second, conducting focus groups with various CHC staff to identify barriers and attitudes toward screening and new strategies like using technology and medical assistant involvement. Third, developing implementation strategies based on these findings and testing them individually at each CHC using a design where each center acts as its own control. Strategies may include patient text messages, staff training, and workflow changes. Participants, who are CHC staff involved in colorectal cancer screening, will engage in focus groups and implementation testing lasting about four months. Researchers will collect data on how acceptable, feasible, and appropriate the strategies are through surveys and observation. They will also measure changes in screening rates. The study uses detailed data management and analysis methods to track progress and outcomes, aiming to tailor and optimize screening interventions in these health centers.
CONDITIONS
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
A
Adjoa Anyane-Yeboa, MD, MPH
N
Nathan Yoguez, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Massachusetts General Hospital
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Rapid Implementation Strategies | Usual Practice (No Active Implementation) |
|---|---|---|
| What it is | Rapid-cycle behavioral strategies chosen to address identified local barriers to colorectal cancer screening. Includes focus groups, matching strategies to needs, and active testing at community health centers. | Routine colorectal cancer screening practice as conducted by staff at the same sites without research-driven implementation strategies. |
| Role in trial | Serves as the intervention period: staff engage in focus groups, select, and enact tailored strategies aimed to increase CRC screening rates. | Acts as the control: staff return to their usual CRC screening procedures, without active intervention or process change. |
| Primary use | To identify and address real-world barriers to colorectal cancer screening, improving implementation processes and acceptability among staff. | To provide a baseline for evaluating the impact of implementation strategies, reflecting standard CRC screening workflow and practices. |
| How it is given or performed | Strategies are chosen based on feedback from focus groups with staff, matched to local needs, and implemented at patient, provider, and system levels. | Staff continue standard processes for CRC screening, without modification, additional training, or intervention. |
| Evidence status | Effectiveness for increasing CRC screening rates among staff populations is under study. Behavioral implementation strategies have shown positive impact when tailored to local needs in health centers, but results for this approach at these sites are not yet established. | Routine practice in community health centers often faces persistent barriers, leading to lower screening uptake compared to recommended guidelines. Evidence shows common challenges include time constraints, lack of resources, and limited patient outreach. |
| Important limitations | Pilot results from this setting are not yet published, and impact may vary by site. It remains unclear which specific strategies are most effective, and broader implementation could face resource constraints. | Routine practice may lack resources and systematic approaches to overcoming staff and patient screening barriers. Screening rates may remain below guideline recommendations. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 4 months
Participants engage in focus groups and help identify barriers and facilitators to colorectal cancer screening. Based on this, implementation strategies at the patient, provider, and system levels will be developed and tested using rapid cycle methods including systematic introduction and withdrawal of strategies.
Multiple visits depending on implementation strategy testing at each health center
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
SCREENING
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rebecca L Siegel, Stacey A Fedewa, William F Anderson...
https://pubmed.ncbi.nlm.nih.gov/28376186/A S O'Malley, E Beaton, K R Yabroff...
https://pubmed.ncbi.nlm.nih.gov/15207986/Dennis J Ahnen, Sally W Wade, Whitney F Jones...
https://pubmed.ncbi.nlm.nih.gov/24393412/Jesse Dallery, Bethany R Raiff
https://pubmed.ncbi.nlm.nih.gov/25264468/John Ward-Horner, Peter Sturmey
https://pubmed.ncbi.nlm.nih.gov/21541152/Rebecca L Siegel, Kimberly D Miller, Ann Goding Sauer...
https://pubmed.ncbi.nlm.nih.gov/32133645/Karen E Lasser, John Z Ayanian, Robert H Fletcher...
https://pubmed.ncbi.nlm.nih.gov/18304342/Andrew M D Wolf, Elizabeth T H Fontham, Timothy R Church...
https://pubmed.ncbi.nlm.nih.gov/29846947/B Alex Matthews, Ruric C Anderson, Ann B Nattinger
https://pubmed.ncbi.nlm.nih.gov/16049812/Tiffany Brown, Ji Young Lee, Jessica Park...
https://pubmed.ncbi.nlm.nih.gov/26844165/Massachusetts General Hospital
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor